Envoy MedicalCOCH
13F holders, Q3 2024 (September 30)18holders −2
2new positions
5sold out
$3.22avg. 13F price*
At the end of Q3 2024, 18 institutions reported holding Envoy Medical Inc. (COCH) in their 13F filings, down 2 from Q2 2024. 2 opened new positions and 5 sold out. The largest holders were Atlas Merchant Capital LLC ($1.8M), Vanguard Group Inc. ($604K) and Geode Capital Management, LLC ($288K).
- Company
- Envoy Medical Inc.
- CUSIP
- 29415V109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $105K |
| Exits | 5 | $597K |
All 13F filers, Q2 2024 → Q3 2024: 119,297 shares bought and 256,323 shares sold, net −137,026 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Atlas Merchant Capital LLC | 2.80% | No change | 555,527 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +60.4% | 185,961 | $604K |
| Geode Capital Management, LLC | 0.00% | Add +1.8% | 88,544 | $288K |
| Corient Private Wealth LP | 0.00% | No change | 38,162 | $124K |
| Morgan Stanley | 0.00% | No change | 31,541 | $103K |
| HighPoint Advisor Group LLC | 0.01% | New | 38,662 | $99K |
| State Street Corp. | 0.00% | No change | 23,872 | $78K |
| BlackRock, Inc. | 0.00% | — | 15,759 | $51K |
| Northern Trust Corp. | 0.00% | No change | 14,043 | $46K |
| Marquette Asset Management, LLC | 0.01% | No change | 11,718 | $38K |
| WealthTrust Asset Management, LLC | 0.03% | No change | 11,316 | $37K |
| Osaic Holdings, Inc. | 0.00% | Add +233.3% | 10,000 | $33K |
| Safe Harbor Fiduciary, LLC | 0.01% | — | 2,500 | $8K |
| American Capital Advisory, LLC | 0.00% | New | 2,000 | $7K |
| Wells Fargo & Company | 0.00% | Reduce -29.4% | 1,938 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -67.5% | 1,312 | $4K |
| Bank of America Corp. | 0.00% | Add +29.8% | 74 | $240 |
| JPMorgan Chase & Co. | 0.00% | No change | 21 | $68 |
"% of holder's portfolio" is COCH's weight in each manager's 13F, not the share of Envoy Medical Inc. the manager owns.